Skip to main content
Equibles

MORGAN STANLEY

Position in RNAC — Cartesian Therapeutics, Inc.

CIK 895421 NEW YORK, NY
Back to RNAC Full portfolio

Position in RNAC

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$100,938
+$9,888 QoQ
Shares Held
9,687
-34.6% QoQ
Ownership
0.032%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#55
of 95 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in RNAC Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

MORGAN STANLEY holds $16,838,649,954 across 523 Biotechnology names. RNAC ranks #346 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 RPRX
Royalty Pharma plc
 42,931,597 $2,407,174,637
2 VRTX
Vertex Pharmaceuticals Inc / Ma
 3,242,139 $1,610,467,694
3 ROIV
Roivant Sciences Ltd.
 42,592,905 $1,507,362,901
4 REGN
Regeneron Pharmaceuticals, Inc.
 1,397,712 $871,529,332
5 MRNA
Moderna, Inc.
 9,538,094 $667,952,718
6 ARGX
Argenx SE
 643,123 $596,670,219
7 TECH
BIO-TECHNE Corp
 6,374,717 $450,373,747
8 INCY
Incyte Corp
 2,948,364 $334,226,536

All Filings in RNAC

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $100,938 9,687
2026-03-31 $91,050 14,805
2025-12-31 $167,949 23,294
2025-09-30 $193,912 18,974
2025-06-30 $303,523 29,213
2025-03-31 $235,261 17,850
2024-12-31 $434,530 24,262
2024-09-30 $354,815 22,011
2024-06-30 $195,740 7,247
2024-03-31 $143,611 220,942
2023-12-31 $196,284 284,885
2023-09-30 $182,798 172,453
2023-06-30 $283,841 253,431
2023-03-31 $373,049 268,382
2022-12-31 $162,025 143,387
2022-09-30 $149,935 91,425
2022-06-30 $1,217,126 929,107
2022-03-31 $1,016,308 826,269
2021-12-31 $4,203,337 1,289,368
2021-09-30 $2,017,658 485,015
2021-06-30 $2,026,713 484,860
2021-03-31 $3,719,848 822,066
2020-12-31 $3,996,662 1,319,031
2020-09-30 $32,655 13,168
2020-06-30 $439,000 154,578
2020-03-31 $52,142 21,636